Aquestive Therapeutics Inc (AQST)vsUnited Therapeutics Corporation (UTHR)
AQST
Aquestive Therapeutics Inc
$3.46
-6.61%
HEALTHCARE · Cap: $491.44M
UTHR
United Therapeutics Corporation
$554.73
-0.78%
HEALTHCARE · Cap: $25.07B
Smart Verdict
WallStSmart Research — data-driven comparison
United Therapeutics Corporation generates 6427% more annual revenue ($3.19B vs $48.84M). UTHR leads profitability with a 38.6% profit margin vs -162.3%. UTHR earns a higher WallStSmart Score of 55/100 (C).
AQST
Avoid18
out of 100
Grade: F
UTHR
Buy55
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-52.8%
Fair Value
$2.50
Current Price
$3.46
$0.96 premium
Margin of Safety
+2.4%
Fair Value
$487.77
Current Price
$554.73
$66.96 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Keeps 39 of every $100 in revenue as profit
Safe zone — low bankruptcy risk
Strong operational efficiency at 29.0%
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
ROE of 0.0% — below average capital efficiency
Weak financial health signals
Expensive relative to growth rate
4.1% revenue growth
Earnings declined 20.3%
Comparative Analysis Report
WallStSmart ResearchBull Case : AQST
The strongest argument for AQST centers on Debt/Equity.
Bull Case : UTHR
The strongest argument for UTHR centers on Profit Margin, Altman Z-Score, Operating Margin. Profitability is solid with margins at 38.6% and operating margin at 29.0%.
Bear Case : AQST
The primary concerns for AQST are EPS Growth, Market Cap, Return on Equity.
Bear Case : UTHR
The primary concerns for UTHR are PEG Ratio, Revenue Growth, EPS Growth.
Key Dynamics to Monitor
AQST profiles as a turnaround stock while UTHR is a value play — different risk/reward profiles.
AQST carries more volatility with a beta of 1.50 — expect wider price swings.
UTHR is growing revenue faster at 4.1% — sustainability is the question.
UTHR generates stronger free cash flow (126M), providing more financial flexibility.
Bottom Line
UTHR scores higher overall (55/100 vs 18/100), backed by strong 38.6% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Aquestive Therapeutics Inc
HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC · USA
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and marketing various products to address unmet medical needs in the United States and internationally. The company is headquartered in Warren, New Jersey.
United Therapeutics Corporation
HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC · USA
United Therapeutics Corporation, a biotechnology company, is dedicated to the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company is headquartered in Silver Spring, Maryland.
Visit Website →Compare with Other DRUG MANUFACTURERS - SPECIALTY & GENERIC Stocks
Want to dig deeper into these stocks?